Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes

OBJECTIVE: Early results of a randomised trial showed reduced fibrosis due to recurrent HCV hepatitis with tacrolimus triple therapy (TT) versus monotherapy (MT) following transplantation for HCV cirrhosis. We evaluated the clinical outcomes after a median 8 years of follow-up, including differences...

Descripción completa

Detalles Bibliográficos
Autores principales: Manousou, Pinelopi, Cholongitas, Evangelos, Samonakis, Dimitrios, Tsochatzis, Emmanuel, Corbani, Alice, Dhillon, A P, Davidson, Janice, Rodríguez-Perálvarez, Manuel, Patch, D, O'Beirne, J, Thorburn, D, Luong, TuVinh, Rolles, K, Davidson, Brian, McCormick, P A, Hayes, Peter, Burroughs, Andrew K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033276/
https://www.ncbi.nlm.nih.gov/pubmed/24131637
http://dx.doi.org/10.1136/gutjnl-2013-305606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033276/
https://www.ncbi.nlm.nih.gov/pubmed/24131637
http://dx.doi.org/10.1136/gutjnl-2013-305606

Ejemplares similares